Quality Level
description
Configurable Rat Cardiac Injury 7-Plex Panel 1
species reactivity
rat
manufacturer/tradename
Milliplex®
packaging
1 ea of
assay range
recovery range: 80-100%
(2 Hour Protocol)
recovery range: 86-103%
(Overnight Protocol)
sensitivity: 7-155 pg/mL
(Overnight Protocol; MinDC+2SD)
sensitivity: 9-86 pg/mL
(2 Hour Protocol; MinDC+2SD)
standard curve range: 123-90,000 pg/mL
(cTnI)
standard curve range: 21-15,000 pg/mL
(CKM)
standard curve range: 4-3,000 pg/mL
(MYL3)
standard curve range: 41-30,000 pg/mL
(FABP3)
standard curve range: 41-30,000 pg/mL
(TIMP-1)
standard curve range: 82-60,000 pg/mL
(FSTL1)
standard curve range: 82-60,000 pg/mL
(cTnT)
technique(s)
multiplexing: suitable
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
Legal Information
Application
Analytes Included: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT), Creatine Kinase Muscle (CKM), FABP3, Follistatin-like Protein 1 (FSTL1), Myosin Light Chain 3 (MYL3), TIMP-1
Assay Characteristics: Refer to the assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
Features and Benefits
- Includes 7 key biomarkers of cardiac injury and stress
- Targets structural, enzymatic, and regulatory proteins involved in myocardial damage
- Designed for use with rat serum or plasma samples
- Compatible with Luminex® xMAP® technology for multiplex analysis
- Verified for high sensitivity, specificity, and reproducibility
- Enables early and accurate detection of cardiac injury in preclinical models
- Supports research in cardiotoxicity, ischemia, heart failure, and drug safety studies
- Reduces sample volume requirements while increasing data throughput
- Improves efficiency in biomarker discovery and translational cardiovascular research
- Facilitates high-throughput screening with consistent and reliable results
General description
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
target_organs
Respiratory Tract
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
法规信息
相关内容
Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.
Uncover tips and tricks to multiplexing in this guide from the experts. Learn how you can enhance the power of your research with MILLIPLEX® multiplexing, including industry guidance for immunoassays, multiplexing tips, one-day MILLIPLEX® multiplex assays for limited lab time, and more.
了解在实验室、伴生和农业动物研究中使用生物标志物多重免疫检测产品的优势，探索MILLIPLEX®多重检测试剂盒在兽医学和动物健康研究方面的应用。
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持